Xponance, Inc. Adma Biologics, Inc. Transaction History
Xponance, Inc.
- $10.1 Billion
- Q1 2025
A detailed history of Xponance, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 25,947 shares of ADMA stock, worth $527,761. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,947
Previous 28,912
10.26%
Holding current value
$527,761
Previous $495,000
3.84%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$379 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$343 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$262 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$233 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$115 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.99B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...